Akerna's MJ Freeway Consulting team adds New Jersey to its list of clean sweep states for assisting clients in winning cannabis licenses

Akerna's consulting team has a 100% success track record in assisting clients on licensing applications in four states, with additional wins in more than a dozen other states  

DENVER, April 7, 2022 /PRNewswire/ -- Akerna (Nasdaq: KERN), a leading enterprise software company and the developer of one of the most comprehensive technology infrastructures, ecosystems, and compliance engines powering the global cannabis industry, today announces its MJ Freeway Cannabis Consulting team was 100% successful in assisting its New Jersey client base on winning cannabis license applications. 

Akerna's success in the New Jersey market is just the latest clean sweep win for its consulting team, with 100% success in three other markets and additional wins in over a dozen other states. 

"Our consulting team works closely with their clients to understand their operational objectives and assist them in building their unique application strategy," said Jessica Billingsley, Akerna Chief Executive Officer. "With multiple legalization efforts happening across the country and globe, Akerna's MJ Freeway Cannabis Consulting team remains poised to assist clients in capitalizing on the opportunities these emerging states present."

"We are thrilled to have assisted clients to win every license applied for in four states," said Sheri Springer, Director of Consulting Service Sales at Akerna's MJ Freeway Cannabis Consulting Team. "These states had incredibly competitive markets, and our team's undefeated track record in them is a testament to their skills. With success in 18 states, we are a clear leader in the cannabis consulting space." 

Akerna's MJ Freeway Cannabis Consulting team has 30+ years of combined experience in the medical and adult-use cannabis industry. The consulting team helps interested parties learn how to win a license, build, set up, open, operate, and scale a successful cannabis business and has completed applications in 18 different states with a highly successful track record. To learn more, visit: mjplatform.com/cannabis-consulting/team/    

To request a consultation with the consulting team, visit: mjplatform.com/request-a-consultation/

For information on recent cannabis legalization and licensing, visit: info.mjplatform.com/cll-state-of-the-union-feb2022

Akerna (Nasdaq: KERN) is an enterprise software company focused on compliantly serving the cannabis, hemp, and CBD industry. First launched in 2010, Akerna has tracked more than $30 billion in cannabis sales to date and is the first cannabis software company listed on Nasdaq. Using connected data and information to propel the cannabis industry forward, Akerna empowers businesses, governments, patients, and consumers to make smart decisions.  

The Company's cornerstone technology, MJ Platform, a leading cannabis infrastructure as a service platform, powers retailers, manufacturers, brands, distributors, and cultivators. Akerna also offers a complete suite of professional consulting services and data analytics for businesses as well as solo sciences, Leaf Data Systems, Trellis, Ample Organics, Viridian Sciences and 365 Cannabis. 

For more information, visit https://www.akerna.com/.   

Certain statements made in this release and any accompanying statements by management are "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. Such forward-looking statements include but are not limited to statements regarding MJ Freeway Cannabis Consulting Team's ability to assist clients in capitalizing on opportunities in emerging cannabis states and teach clients to win a license, build, set up, open, operate, and scale a successful cannabis business and any other statements expressing the views of Akerna's management on future business results or strategy. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of significant known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Akerna's control, that could cause actual results or outcomes (including, without limitation, the results of Akerna's contracts, strategic initiatives, and business plans as described herein) to differ materially from those discussed in the forward-looking statements. Important factors, among others that may affect actual results or outcomes, include (i) Akerna's ability to recognize the anticipated benefits of being a public company, (ii) competition, (iii) Akerna's ability to grow and manage growth profitably, (iv) Akerna's ability to maintain relationships with customers and suppliers and retain its management and key employees, (v) costs related to being a public company, (vi) changes in applicable laws or regulations, (vii) Akerna's ability to identify, complete and integrate acquisitions, including Viridian, and achieve expected synergies and operating efficiencies in connection with acquired businesses, (viii) and other risks and uncertainties disclosed from time to time in Akerna's filings with the U.S. Securities and Exchange Commission, including those under "Risk Factors" therein. Actual results, performance, or achievements may differ materially, and potentially adversely, from any projections and forward-looking statements and the assumptions on which those vary from forward-looking statements are based. There can be no assurance that the data contained herein is reflective of future performance to any degree. You are cautioned not to place undue reliance on forward-looking statements as a predictor of future performance as projected financial and other information, are based on estimates and assumptions that are inherently subject to various significant risks, uncertainties and other factors, many of which are beyond Akerna's control. All information herein speaks only as of the date hereof, in the case of information about Akerna, or the date of such information, in the case of information from persons other than Akerna. Akerna undertakes no duty to update or revise the information contained herein. Forecasts and estimates regarding Akerna's industry and end markets are based on sources believed to be reliable; however, there can be no assurance these forecasts and estimates will prove accurate in whole or in part.

SOURCE Akerna